Navigation Links
Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results
Date:11/6/2009

HOUSTON, Nov. 6 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the second quarter ended October 23, 2009 of its fiscal year ending April 30, 2010 on Wednesday, November 18, 2009 at 5:00 PM EST. The company will conduct a conference call to discuss those results on Thursday, November 19, 2009 at 9:00 AM EST.

Fiscal Year 2010 Second Quarter Results Conference Call Instructions

To listen to the conference call live by telephone dial 877-313-8035 (if dialing from within the U.S.) or 706-679-4838 (if dialing from outside the U.S.). The conference ID is 40115998. Presentation slides will be available on-line at www.cyberonics.com no later than 8:00 AM EST on Thursday, November 19, 2009. A replay of the conference call will be available approximately two hours after the completion of the conference call by dialing 800-642-1687 (if dialing from within the U.S.) or 706-645-9291 (if dialing from outside the U.S.). The replay conference ID access code is 40115998. The replay will be available for one week on the above number and subsequently on the company's website for a period of six months.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberoni
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cyberonics Provides Update on Depression Post-Approval Study
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015   Hospira, ... leader in biosimilars and the world,s leading provider ... studies that support an evaluation of biosimilarity of ... Food and Drug Administration (FDA) conditionally approved name ... EPOGEN™ (epoetin alfa). These study data were presented ...
(Date:3/27/2015)... 27, 2015 Concord Medical Services Holdings ... CCM ), a leading specialty hospital management solution ... radiotherapy and diagnostic imaging centers in ... a purchase agreement under which Concord Medical Services ... the Company, agreed to acquire the Fortis Surgical ...
(Date:3/26/2015)... 26, 2015 "Whether it,s our family, our ... In a single sentence, Dr. Anthony ... at Pfizer,s Centers for Therapeutic Innovation (CTI), ... progress at America,s biopharmaceutical companies. CTI,s ... academia, patient foundations and the National Institutes of Health ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
... American Association for Cancer Research Aims to Raise Awareness about,the Importance of Clinical ... Most Americans with cancer would be receptive to participating in ... -- In a survey of 6,000 cancer patients, 85 percent ... unsure that participation in a clinical trial was an option. ...
... Arpida,Ltd. (SWX: ARPN) today announced the completion ... with oral iclaprim in patients with,complicated Skin and ... designed as a multi-centre, double-blind comparative,study. Patients suffering ... two days of treatment and were then randomised ...
Cached Medicine Technology:Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs 2Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs 3Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim 2Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim 3
(Date:3/27/2015)... 27, 2015 California’s ongoing worst ever ... Boston and the United States Northeast, are both manifestations ... global atmosphere is creating changes in the atmosphere’s “energy ... and former NASA researcher, speaking on the Sharon Kleyne ... not only a warmer and dryer global climate but ...
(Date:3/27/2015)... To address their number one lawn care question which ... this video to explain the complicated dynamics between the light ... expected to thrive in, be it in dense building or ... Anytime a sun-loving plant is put in the shade the ... try to amend this issue by applying large quantities of ...
(Date:3/27/2015)... Franklin Lakes, New Jersey (PRWEB) March 27, 2015 ... emerging teenage singer-songwriter-actress has released the official music video ... Kmina Entertainment label. , Combining live-action and abstract ... song already can be viewed on YouTube, Vimeo, and ... to popularize in the development of an expanding full-scale ...
(Date:3/27/2015)... VXi BlueParott Reveal ” was featured on NewsWatch as ... latest and coolest technology products available to consumers. Scott ... conducted the review and shared with viewers how this ... noise. , Today, business is all about productivity on-the-go. ... professional, voice calls are just as important. But having ...
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 ... is a Quaker-based, philanthropic, grant-making foundation committed to ... which behavioral healthcare is delivered. , The Scattergood ... that advance Behavioral Health Policy and Practice through ... SoundsLikeIBS Program App is designed to ...
Breaking Medicine News(10 mins):Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2
... Calif., Nov. 24 Visage Imaging(R),Inc., a ... Inc.,(NASDAQ: MRCY ), announced it ... Inc., a leading developer of 2D/3D medical ... Imaging will act as a,representative for Viatronix,s ...
... the,first and only U.S. Food and Drug Administration (FDA) ... Disease (HD), is now,available in the United States. ... decades for a single treatment option. The,Huntington,s Disease ... time,ever people with HD will have an approved option ...
... West Cal Cam becomes 181st Site in Southeast to Choose ... Nov. 24 Global Med Technologies(R), Inc. ("Global Med") (OTC ... today announced that its Wyndgate Technologies(R) ("Wyndgate") division has licensed ... ("West Cal Cam") of Sulphur, Louisiana. Terms of the ...
... a wholly owned subsidiary of Mercury Computer Systems, Inc.,(NASDAQ: ... Beebe Medical Center to provide,its enterprise-wide Visage(R) CS Thin ... Based in Lewes, Delaware, the Beebe Medical ... mission to encourage healthy,living, prevent illness, and restore optimal ...
... tests may be needed to detect rising blood pressure ... (HealthDay News) -- Young black American men have higher ... males, indicating that black men are developing high blood ... signs, according to a study by researchers at the ...
... Corporation,(Nasdaq: THOR ), a world leader in ... falling hearts, said today that it will,be participating in ... December 3. , Gary Burbach, president and ... beginning at 1 p.m., Eastern Standard Time (10 a.m.,Pacific ...
Cached Medicine News:Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 2Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 3Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 4Health News:The First Treatment Specifically Approved for Huntington's Disease Patients is Now Available in the United States 2Health News:Gulf Coast Hospital Chooses Global Med Technologies(R)' Blood System 2Health News:Gulf Coast Hospital Chooses Global Med Technologies(R)' Blood System 3Health News:Gulf Coast Hospital Chooses Global Med Technologies(R)' Blood System 4Health News:Visage Imaging to Provide Enterprise-Wide Thin Client Solutions to Beebe Medical Center 2Health News:Visage Imaging to Provide Enterprise-Wide Thin Client Solutions to Beebe Medical Center 3Health News:Visage Imaging to Provide Enterprise-Wide Thin Client Solutions to Beebe Medical Center 4Health News:Hypertension May Hit Black Males Earlier 2
... A CMV assay for screening donors on ... CMV-PA System uses CMV antigen attached to ... cytomegalovirus. Relative sensitivity and specificity of the ... 99.8% and 99.3% respectively. The use of ...
... microplate agglutination technology. Its is a fully ... testing. PK7200 also handles weak D as ... The Automated Microplate System delivers the very ... that for the past generation has tested ...
... fully automated blood bank ... American market based on ... The ORTHO ProVue™ eliminates ... increasing productivity via random ...
... are in need of MRI exams, many ... scanners. They have heard of, or experienced ... and noisy tubes of supercon scanners - ... people want is a patient-friendly MRI. Now ...
Medicine Products: